The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update with Annie West and Dae Lee

Sykes & Company, P.A.

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 30:11

Send us Fan Mail

Schedule an Rx Assessment

A LOT has happened recently in the Peptide market, but what exactly is new with peptides, the FDA, and the future of independent pharmacy?

On this episode of the Bottom Line Pharmacy Podcast, we're joined for our typical quarterly pharmacy update with  ⁨@atrium24⁩ . Annie West, Clinical Pharmacy Director and Dae Lee, PBM & Pharmacy Practice Group Board Co-Chair at Buchanan, Ingersoll & Rooney, P.C. to break down:

  • The two-day PCAC meeting and the committee's recommendation
  • What happens next in the FDA rulemaking process 
  • The dangerous peptide gray market
  • The latest on PBM policy

And more!

Stay connected with Atrium24 and Dae Lee:

Dae Lee LinkedIn

Atrium24 Website

Atrium24 LinkedIn

Atrium24 Instagram

Atrium24 Facebook

Stay connected with us:

Facebook

Twitter

LinkedIn

Scotty Sykes – CPA, CFP LinkedIn

Scotty Sykes – CPA, CFP Twitter

Bonnie Bond – CPA LinkedIn

Bonnie Bond – CPA Twitter

More resources on this topic:


Podcast - Inside a Pharmacy AI Bot: Automating Independent Pharmacy

Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24

Podcast – 2026 Quarter 2 Pharmacy Update

Podcast – R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.

The Pharmacy Ownership Podcast Artwork

The Pharmacy Ownership Podcast

Sykes & Company, P.A.
Pharmacy Podcast Network Artwork

Pharmacy Podcast Network

Pharmacy Podcast Network